Crawford Downs, Ph.D., has been named chair-elect of the Animals in Research Committee of the Association for Research in Vision Science and Ophthalmology.
The University of Alabama Board of Trustees approved the creation of the Personalized Medicine Institute, the Institute for Informatics and the UAB-HudsonAlpha Center for Genomic Medicine.
The UAB-HudsonAlpha Center for Genomic Medicine will span human genome research with clinical care.
Neurologist David Geldmacher, M.D., is launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
Anthony Nicholas, M.D., associate professor in the Department of Neurology, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Researchers participated in a multi-site study that disproved a once-promising theory that statins might have a beneficial effect on lung function.
Researchers at the University of Alabama at Birmingham have identified a strategy that highly aggressive brain tumor cells use to fuel their relentless expansion.
UAB researchers have created a blood test that determines a bioenergetic index which could become an important method of measuring mitochondrial health in patients with chronic disease.